Targeting the CD134–CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis
Lupus nephritis (LN) is characterized by an increased upregulation of Th1. This study was undertaken to evaluate the role of CD134 in cytokine production in peripheral blood mononuclear cells (PBMCs) from subjects with LN. Percentages of IFN-γ- (Th1), IL-4-, and IL-10- (Th2) producing cells within the PBMC CD4+ T cell population of LN subjects were found to be higher than those of healthy subjects. Stimulation of PBMC from LN subjects with anti-CD3 ε mAb/rIL-2 resulted in further increases in cytokine production. Stimulation in the presence of anti-CD134 mAb resulted in reduced IL-4 and IL-10 production; however, it also resulted in increased IFN-γ production. Stimulation in the presence of the fusion protein rhCD134:Fc resulted in decreased production of all three cytokines. The possibilities that anti-CD134 therapy may control the extent of IL-4- and IL-10-mediated damage in active LN and that rhCD134:Fc therapy may prevent occurrence of LN are discussed.
KeywordsAnti-CD134 mAb Cytokines Lupus nephritis RhCD134 T helper cell balance
- 11.Higgins LM, McDonald SA, Whittle N et al (1999) Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol 162:486–493PubMedGoogle Scholar
- 15.Ye RG (2000) Systemic lupus erythematosus. In: Textbook of internal medicine. People’s Publishing House of Public Health, Beijing City, pp 909–915Google Scholar
- 18.Huang H, Yu H, Xiong SD (2001) Enhancement of anti-CD4 mAb on anti-tumor activity of tumor-specific T cells activated by rIL-2 and anti-CD3 mAb. J Cell Mol Immunol 17:160–164Google Scholar
- 19.Yi-wei C, Fox BA (2001) Induction of tumor-specific Th1 cell response in vitro by anti-OX-40 and anti-IL-4. Shanghai J Immunol 21:148–150 ChineseGoogle Scholar
- 20.Zhou YB, Li YJ, Wu YH (2006) Study on the levels in the serum and mRNA expression in PBMCs of interleukin-10 and interferon-γ of patients with lupus nephritis. China J Mod Med 16:529–532 ChineseGoogle Scholar